There’s strength in numbers, especially when it comes to cell therapy. Now Orca Bio and Lyell Immunopharma — both Engine Room clients — are teaming up to develop CAR-T for treating solid tumors.

For treating blood cancers in some patients, CAR-T has been a big hit. Trials on tumors have not gone as well. Still, big potential exists. With their new R&D pact, Orca and Lyell will join forces to generate “potentially synergistic therapeutic solutions for solid tumors.” Read more at Fierce Bio.